What is the Anlon Healthcare Ltd share price today?

The share price of NSE:AHCL-EQ on 01 Oct 2026 (as of 15:02:59 IST) is ₹32.86.

What is the NSE:AHCL-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:AHCL-EQ 52 week high low range shows a high of ₹37.24 and a low of ₹10.371.

What is the Anlon Healthcare Ltd market cap?

As on 01 Oct 2026, Anlon Healthcare Ltd market cap is ₹18432900000.

What is the shareholding pattern of Anlon Healthcare Ltd Stock?

The shareholding pattern of Anlon Healthcare Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 52.68% Foreign Institutional Investors (FII): 1.67% Domestic Institutional Investors (DII): 1.23% Mutual Funds: 0% Retail & Others: 44.42% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Anlon Healthcare Ltd?

The Price-to-Earnings (PE) ratio of Anlon Healthcare Ltd is 64.6457, and the Price-to-Book (PB) ratio is 2.5695, as on 01 Oct 2026.

Anlon Healthcare Share Price

26.67+1.27 (+5.00%)

+97.57% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+5.00%

1 Week

+3.01%

1 Month

-14.57%

3 Month

+87.68%

6 Month

+89.42%

YTD

+76.68%

1 Year

+97.57%

5 Year

10 Year

Max

+189.89%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

25.00

24.60

23.14

13.97

13.14

10.37

High

26.67

31.22

37.24

About

Anlon Healthcare is a chemical manufacturing company, engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets. Its Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

AHCLNSE

LTP

1W Low

1W High

Market cap (₹)

1795.4+17.7 (1.00%)

1722

1810.40

4,25,150Cr

10007+227 (2.32%)

9863

10067

2,66,265Cr

4681.6+68.2 (1.48%)

4553

4698.50

1,76,301Cr

2321.7-83.8 (-3.48%)

2252.40

2441.90

1,25,352Cr

1187-58.5 (-4.70%)

1182.60

1266.60

1,23,591Cr

1367.8+15.8 (1.17%)

1336.70

1376.70

1,14,351Cr

1391.2+12.3 (0.89%)

1364.60

1400.80

1,12,474Cr

2484.5-8.3 (-0.33%)

2457.90

2512.30

1,02,315Cr

1710+28.6 (1.70%)

1656.20

1713.80

97,757Cr

2032.2+21.2 (1.05%)

1988.90

2062.10

92,007Cr

26.5+0.61 (2.36%)

24.60

26.60

1,349Cr

Anlon Healthcare Share Price

26.67+1.27 (+5.00%)

+97.57% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year43%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year42%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year88%

Return on Equity

10 years22%

5 years22%

3 years22%

Last year19%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	43%
-	-	-	42%
-	-	-	88%
22%	22%	22%	19%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

AHCL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,789	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
10,002.5	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,687.4	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,322.1	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,207	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,369.5	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,396.1	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,507.9	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,714.7	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,020	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
26.67	₹1349 Cr	47.31	0.25	0.57	₹29 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Sep 2025	Jun 2025	Mar 2025
₹106 Cr	₹88 Cr	₹51 Cr	₹52 Cr	₹33 Cr	₹49 Cr
₹5 L	₹6 L	₹1 L	₹3 L	₹1 L	₹4 L
₹106 Cr	₹88 Cr	₹51 Cr	₹52 Cr	₹33 Cr	₹49 Cr
₹81 Cr	₹73 Cr	₹36 Cr	₹39 Cr	₹27 Cr	₹33 Cr
₹25 Cr	₹16 Cr	₹15 Cr	₹14 Cr	₹6 Cr	₹17 Cr
₹86 L	₹93 L	₹57 L	₹84 L	₹82 L	₹91 L
₹23 Cr	₹14 Cr	₹14 Cr	₹12 Cr	₹5 Cr	₹15 Cr
₹17 Cr	₹8 Cr	₹11 Cr	₹9 Cr	₹4 Cr	₹17 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025
—	—
₹53 Cr	₹40 Cr
₹177 Cr	₹41 Cr
₹177 Cr	₹41 Cr
₹230 Cr	₹80 Cr
₹25 Cr	₹0
₹6 Cr	₹5 Cr
₹4 L	₹34 Cr
₹5 Cr	₹2 Cr
₹37 L	₹24 L
₹12 Cr	₹41 Cr
—	—
₹42 Cr	₹20 Cr
₹14 Cr	₹4 Cr
₹38 Cr	₹28 Cr
₹14 Cr	₹8 Cr
₹108 Cr	₹60 Cr
₹374 Cr	₹181 Cr
₹25 L	₹0
₹44 Cr	₹67 Cr
—	—
₹84 Cr	₹36 Cr
₹26 Cr	₹13 Cr
₹58 Cr	₹23 Cr
₹98 L	₹0
₹98 L	₹0
₹7 Cr	₹0
₹66 Cr	₹23 Cr
—	—
₹1 L	₹91 L
₹113 Cr	₹50 Cr
₹104 Cr	₹75 Cr
₹4 Cr	₹1 Cr
₹1 Cr	₹1 Cr
₹86 Cr	₹30 Cr
₹308 Cr	₹158 Cr
₹201 Cr	₹98 Cr
₹374 Cr	₹181 Cr
₹43	₹20
₹4	₹2

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025
₹43 Cr	₹27 Cr
₹5 Cr	-₹56 L
-₹122 Cr	-₹54 Cr
-₹75 Cr	-₹28 Cr
-₹79 Cr	-₹23 Cr
-₹36 Cr	₹3 Cr
₹119 Cr	₹19 Cr
₹3 Cr	-₹82 L
₹1 Cr	₹2 Cr
₹4 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Anlon Healthcare Share Price

26.67+1.27 (+5.00%)

+97.57% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Anlon Healthcare Share Price

26.67+1.27 (+5.00%)

+97.57% past 1 Year

Shareholding summary

Promoters

52.68%

FII

0.99%

DII

0.3%

Others

46.03%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025
52.68%	52.68%	52.68%	52.68%	52.68%
0.99%	1.67%	0.32%	0.23%	0.00%
0.30%	1.23%	4.60%	4.49%	2.83%
0.00%	0.00%	0.00%	0.00%	0.00%
46.03%	44.42%	42.40%	42.60%	44.49%

Bulk & block deals

Name

Neo Apex Share Broking Services Llp

Junomoneta Finsol Private Limited

Nk Securities Research Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
08 Oct 2026	Sell	16.81 Cr	₹26.81	62.72 L	Bulk	11.799347	NSE
08 Oct 2026	Purchase	14.51 Cr	₹26.78	54.17 L	Bulk	10.191923	NSE
06 Oct 2026	Purchase	17.40 Cr	₹29.70	58.59 L	Bulk	11.022276	NSE
06 Oct 2026	Sell	4.23 Cr	₹29.76	14.21 L	Bulk	2.673815	NSE
30 Sep 2026	Sell	9.35 Cr	₹34.62	27.02 L	Bulk	5.083	NSE
30 Sep 2026	Purchase	18.05 Cr	₹34.66	52.09 L	Bulk	9.800041	NSE
29 Sep 2026	Sell	10.01 Cr	₹36.39	27.50 L	Bulk	5.17389	NSE
29 Sep 2026	Purchase	6.37 Cr	₹36.39	17.50 L	Bulk	3.292475	NSE
25 Sep 2026	Sell	9.69 Cr	₹30.16	32.13 L	Bulk	6.044783	NSE
25 Sep 2026	Sell	9.94 Cr	₹30.15	32.98 L	Bulk	6.205719	NSE

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Anlon Healthcare Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Anlon Healthcare Share Price

Anlon Healthcare Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Anlon Healthcare Share Price

Anlon Healthcare Share Price

Oscillators

Moving averages

Anlon Healthcare Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Anlon Healthcare Share Price

Corporate Actions

Company details

Anlon Healthcare Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Anlon Healthcare Share Price

News

Anlon Healthcare Reports Higher Second Quarter EBITDA With Lower Margin

AHCL Q2 standalone net profit declines year on year

Anlon Healthcare Reports Stronger Second Quarter Revenue Growth

Anlon Healthcare Approves Convertible Warrants Issue Worth Up To Rs 250 Crores

AHCL reports Rs 20.54 crores NSE block trade involving 6,870,493 shares

Anlon Healthcare guides for 30 percent revenue CAGR over next three years

Anlon Healthcare Q1 revenue declines year-on-year, modest topline pressure observed

Anlon Healthcare reports higher Q1 EBITDA and improved margin year on year

Anlon Healthcare Q1 net profit rises year-on-year to Rs 4.80 crores

Anlon Healthcare informs about invitation for tv interview

Anlon Healthcare informs about conference call

Anlon Healthcare informs about press release

Anlon Healthcare informs about newspaper advertisement

Anlon Healthcare informs about press release

Anlon Healthcare reports Profit after tax of 9.79 Crores, in the March 2026 quarter

Anlon Healthcare Q4 EBITDA declines with significant compression in margins YoY

Anlon Healthcare Q4 reports year-on-year revenue growth for FY2024 period

Anlon Healthcare reports lower Q4 net profit year on year

Anlon Healthcare informs about allotment of bonus equity shares

Anlon Healthcare informs about share purchase agreement

Anlon Healthcare Ltd Share Price Today

Anlon Healthcare Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator